Wow , quite an impressive list of  indications for Apabetalone which several have peer reviewed  publications for. At this point i can't understand  for the life of me why not 1 BP hasn't taking an interest?? price too high that dm is asking for in a buyout.... , doubt that the  best price can be negotiated in a CVR type deal, How about DM being a horrible negotiator(possible) but i would think at high level discussions other more knowledgeable personal could be brought in to help establish a the best deal possible for bith parties.  Which leave us to the conspiratists who believe BP want nothing of this disruptive technology to their existing drug pipeline.  Hold on...  couldn't a BP just buy the technology and either bury it or hold to it until its needs to extend the patents on some synergistic drugs with Apabetalone??  Inquring minds want to know....